BusinessBiodesix Announces Biomarker Research Collaboration with Checkmate PharmaceuticalsBy Nasdaq OMXMar 20, 2018, 1:01 PM UTC
BusinessStopping Epilepsy Before It Starts? CURE Researcher Identifies a Possible BiomarkerBy Nasdaq OMXFeb 6, 2018, 2:50 PM UTC
BusinessZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic MarketsBy Nasdaq OMXFeb 1, 2018, 12:52 PM UTC
BusinessVisiongain launches report entitled Alzheimer’s disease therapeutics and diagnostics market 2017-2027By Nasdaq OMXJan 11, 2018, 1:31 PM UTC
BusinessZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CABy Nasdaq OMXJan 8, 2018, 1:03 PM UTC
BusinessData Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint InhibitorsBy Nasdaq OMXDec 20, 2017, 3:00 PM UTC
BusinessBiodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® TestBy Nasdaq OMXNov 16, 2017, 8:40 PM UTC
BusinessFluidigm to Unveil High-Parameter Tissue Imaging SystemBy Nasdaq OMXOct 18, 2017, 1:01 PM UTC
